Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
The Readout

Biotech loses ground with VCs & personalizing antibiotics

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan Oct. 7, 2016

Reprints
The READOUT
Alex Hogan/STAT

The Readout for October 07, 2016

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

‘It is a balance’: Scientists grapple with ethics of…
‘It is a balance’: Scientists grapple with ethics of cutting-edge stem cell research
The case of RaDonda Vaught highlights a double standard…
The case of RaDonda Vaught highlights a double standard for nurses and physicians
23andMe had devastating news about my health. I wish…
23andMe had devastating news about my health. I wish a person had delivered it
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories